# MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

> **NCT05495893** · PHASE4 · UNKNOWN · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 224 (estimated)

## Conditions studied

- Mycophenolate Mofetil
- Cyclophosphamide
- Lupus Nephritis

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT05495893
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-25
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2022-08-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495893, "MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05495893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*